Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth S G
Praxisgemeinschaft für Neurologie, Psychiatrie, Psychotherapie, Günzstr. 1, 93059, Regensburg, Deutschland.
Behandlungszentrum Kempfenhausen für Multiple Sklerose Kranke gemeinnützige GmbH, Berg, Deutschland.
Nervenarzt. 2018 Apr;89(4):446-452. doi: 10.1007/s00115-017-0442-8.
The symptomatic treatment of multiple sclerosis (MS) is nowadays of similar importance as immunotherapy within a comprehensive treatment concept of this chronic disease. It makes a considerable contribution to the reduction of disabilities in activities of daily living as well as social and occupational life. Moreover, symptomatic treatment is of great importance for amelioration of the quality of life. Since our last survey of symptomatic MS treatment in 2004 and publication of the guidelines of the German Neurological Society and the Clinical Competence Network Multiple Sclerosis (Klinisches Kompetenznetz Multiple Sklerose, KKN-MS) in 2014 several developments within the topics of mobility, bladder and sexual function, vision, fatigue, cognition and rehabilitation have taken place. These new findings together with further aspects of disease measurement methods and overall treatment strategies of the respective symptoms as well as treatment goals are introduced in a series of 6 individual contributions. In this article the symptom of fatigue is discussed.
在多发性硬化症（MS）的综合治疗理念中，对症治疗如今与免疫疗法具有同等重要性。它对减少日常生活活动以及社交和职业生活中的残疾状况做出了相当大的贡献。此外，对症治疗对于改善生活质量也至关重要。自我们上次在2004年对MS对症治疗进行调查以及德国神经病学学会和多发性硬化症临床能力网络（KKN-MS）在2014年发布指南以来，在 mobility、膀胱和性功能、视力、疲劳、认知及康复等主题方面有了多项进展。这些新发现连同疾病测量方法的其他方面、各个症状的整体治疗策略以及治疗目标在一系列6篇独立稿件中进行了介绍。本文讨论疲劳症状。
